Thalidomide-O-amido-PEG3-C2-NH2 (TFA) - HY-103611
Nur noch %1 verfügbar
Catalog #
HY-103611
Ab
52,00 €
Thalidomide-O-amido-PEG3-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology.
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-103611/Thalidomide-O-amido-PEG3-C2-NH2-TFA-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | Cereblon Ligand-Linker Conjugates 3 (TFA); E3 ligase Ligand-Linker Conjugates 14 (TFA) |
| CAS | 1957236-21-3 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 620.53 |
| Solubility | DMSO : 50 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Apoptosis;Autophagy;E3 Ligase Ligand-Linker Conjugates |
| Application: | Cancer-programmed cell death |
|---|